NYSE$SOLV
Solventum Corporation · Q2 2026 earnings
Q2 2026 earnings · · After market close · Investor relations
Briefing
Solventum Corporation reported Q2 2026 results with total net sales of $2.209 billion and net income of $92 million.
Solventum posted Q2 2026 net sales of $2.209 billion, up 2.2% year-over-year, with operating income of $181 million. Net income reached $92 million and diluted EPS was $0.53. The company continued its transformation initiatives while benefiting from advanced customer orders ahead of an ERP deployment.
- Q2 net sales reached $2.209 billion with organic growth of 9.5%.
- MedSurg segment led performance with $1.372 billion in sales and strong operating income margin expansion.
- Dental Solutions delivered 17.0% reported growth driven by new product adoption and advanced orders.
- Cash and cash equivalents stood at $403 million at quarter end with ongoing share repurchases.
Headline financials
Revenue & EPS history
Solventum · Revenue · Quarterly
$2.21B
Revenue by segment
Solventum · $2.21B total across 4 segments · Q2 2026
- MedSurg$1.37B—62.1%
- Dental Solutions$396M—17.9%
- Health Information Systems$354M—16.0%
- All Other$87M—3.9%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 12 quarterly earnings reports
+0.2%
Avg return
Earnings day
+0.1%
Avg return
5 days after
+2.1%
Avg return
30 days after
42%
5 / 12 earnings
Positive
+8.4%
Q2 2024
Best reaction
-4.7%
Q3 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2026 | — | — | — | |
| Q1 2026 | +2.4% | +8.7% | +21.2% | |
| Q4 2025 | -3.7% | -8.5% | -18.4% | |
| Q3 2025 | +7.7% | +11.4% | +28.9% | |
| Q2 2025 | +1.7% | +3.4% | +1.1% | |
| Q1 2025 | +5.5% | +6.8% | +12.3% | |
| Q4 2024 | -4.4% | -6.7% | -10.4% | |
| Q3 2023 | -4.7% | -6.7% | -6.8% | |
| Q3 2024 | -2.3% | -4.6% | -5.6% | |
| Q2 2023 | -1.6% | -1.5% | +12.9% | |
| Q2 2024 | +8.4% | +4.2% | +18.4% | |
| Q1 2023 | -2.6% | -3.7% | -13.0% | |
| Q1 2024 | -4.0% | -2.0% | -15.1% | |
| Q4 2023 | — | — | — | |
| Q4 2022 | — | — | — | |
| Q3 2022 | — | — | — | |
| Q2 2022 | — | — | — | |
| Q1 2022 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro